Recent Posts
- FDA committee votes 12-0 for myeloma trial outcome measure
- CAR T-cell therapy Carvykti OK’d as second-line RRMM treatment
- Abecma OK’d in US to take earlier in treatments for multiple myeloma
- Steroid-free Venclexta combo shows promise in myeloma cells
- Abecma cleared in EU as earlier therapy for hard-to-treat myeloma